| Overview |
| bsm-61831r-apc-cy7-100ul |
| IL-23 Recombinant Antibody, APC-Cy7 Conjugated |
| WB |
| Human |
| Specifications |
| APC-Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human IL 23A |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 51561 |
| Q9NPF7 |
| Secreted |
| IL 23A; IL 23p19; IL12B; IL23; Il23a; IL23P19; P19; SGRF. |
| Associates with IL12B to form the pro-inflammatory cytokine IL-23 that plays different roles in innate and adaptive immunity.Released by antigen-presenting cells such as dendritic cells or macrophages, binds to a heterodimeric receptor complex composed of IL12RB1 and IL23R to activate JAK2 and TYK2 which then phosphorylate the receptor to form a docking site leading to the phosphorylation of STAT3 and STAT4. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz